Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

18.01.17	Technical Reports on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
12.01.17	J&J, Actelion Reportedly Reach Tentative Agreement On Price (RTTNews)
03.01.17	Johnson & Johnson Announces Quarterly Dividend for First Quarter 2017 (PR Newswire)
27.12.16	Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter/Full-Year 2016 Results (PR Newswire)
22.12.16	20% return on Cisco Systems, or get option-trade ideas on Johnson & Johnson, Mondelez International, The Mosaic Company and Under Armour or any stock you choose (PR Newswire)
22.12.16	Johnson & Johnson Resumes Talks With Actelion For Potential Takeover (RTTNews)
21.12.16	Johnson & Johnson Confirms Exclusive Negotiations with Actelion (PR Newswire)
16.12.16	Research Reports on Drug Makers Equities -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
14.12.16	Sanofi Reportedly In Talks For Deal With Actelion (RTTNews)
14.12.16	Johnson & Johnson Ends Takeover Discussions With Actelion (RTTNews)
06.12.16	Bloomberg : Sanofi To Explore Counterbid For Actelion Amid J&J Talks (RTTNews)
02.12.16	Fitbit, bluebird bio Inc., Johnson & Johnson, Skechers, and Diamond Offshore Drilling and more offer option-trading opportunities that offer returns of more than 20% (PR Newswire)
02.12.16	Johnson & Johnson Ordered To Pay More Than $1 Bln For Faulty Hip Implants (RTTNews)
02.12.16	Johnson & Johnson Ordered To Pay More Than $1 Bln For Faulty Hip Implants (RTTNews)
02.12.16	Dallas Jury Returns $1 Billion-Plus Verdict in Defective DePuy Hip Implants Lawsuit (PR Newswire)
26.11.16	Actelion Stock Up As Johnson & Johnson Confirms Talks For Potential Takeover (RTTNews)
25.11.16	Johnson & Johnson Confirms Discussions with Actelion Regarding Potential Transaction (PR Newswire)
25.11.16	J&J Reportedly Makes Takeover Approach For Actelion (RTTNews)
18.10.16	Johnson & Johnson Q3 Profit Tops Estimates; Raises FY16 Adj. EPS Guidance (RTTNews)
18.10.16	Johnson & Johnson Reveals 12% Increase In Q3 Bottom Line (RTTNews)
07.10.16	Astrazeneca In Deal With JNJ Unit To Divest Rights To Rhinocort Aqua Outside US (RTTNews)
25.07.16	J&J's Acclarent To Pay U.S. $18 Mln To Settle False Claims Act Allegations (RTTNews)
19.07.16	Johnson & Johnson Pulls Back Off Record High But Holding On To Gain (RTTNews)
19.07.16	Johnson & Johnson Q2 Results Top Estimates, Lifts FY16 Forecast (RTTNews)
19.07.16	Johnson & Johnson Q2 Income Climbs 1% (RTTNews)
23.06.16	Gilead's STR Odefsey Granted EU Marketing Authorization For Treatment Of HIV (RTTNews)
22.06.16	Johnson & Johnson : VP Of Investor Relations Mehrotra To Retire In January 2017 (RTTNews)
02.06.16	Johnson & Johnson To Buy Vogue Int'l For About $3.3 Bln In Cash (RTTNews)
18.05.16	J&J To Review Strategies For Growth In Consumer, Medical Device Divisions (RTTNews)
03.05.16	J&J Ordered To Pay $55 Mln In Talcum Powder Cancer Trial (RTTNews)
19.04.16	Johnson & Johnson Q1 Adj. Profit Tops View; Lifts FY16 Outlook (RTTNews)
19.04.16	Johnson & Johnson Q1 Income Climbs 6% (RTTNews)
18.04.16	Ahead Of Johnson & Johnson's Q1 Results (RTTNews)
06.04.16	The U.S. Gets 2nd Biosimilar, ORMP Awaits Data This Qtr, PFE Hits Mark In OPAL (RTTNews)
02.03.16	Procter & Gamble To Sell Hipoglós Cream Brand In Brazil To J&J - Quick Facts (RTTNews)
24.02.16	J&J Ordered To Pay $72 Mln In Baby Powder Cancer Lawsuit (RTTNews)
10.02.16	BLPH Heartened, More Trouble For CTIC, Remicade Biosimilar Gets FDA Panel Nod (RTTNews)
02.02.16	Medicxi Ventures Launches As Independent Venture Capital Firm (RTTNews)
26.01.16	Johnson & Johnson Q4 Profit Rises, But Sales Down (RTTNews)
26.01.16	Johnson & Johnson Profit Advances 4% In Q4 (RTTNews)
19.01.16	J&J To Cut 4% To 6% Of Medical Devices Workforce; Sees Charges Of Up To $2.4 Bln (RTTNews)
13.12.15	WSJ: AstraZeneca In Talks To Buy Acerta Pharma For More Than $5 Bln (RTTNews)
17.11.15	FDA Grants Accelerated Approval For J&J's Cancer Drug Darzalex (RTTNews)
13.10.15	Johnson & Johnson Lifts FY15 Outlook As Q3 Adj. Profit Beats View (RTTNews)
13.10.15	Johnson & Johnson Q3 Profit Down; But Raises 2015 Adj. EPS View - Quick Facts (RTTNews)
13.10.15	Johnson & Johnson Earnings Retreat 10% In Q3 (RTTNews)
13.10.15	Johnson & Johnson To Buy Back Up To $10 Bln Of Common Stock (RTTNews)
09.10.15	J&J: Clinical Trial Of Ebola Vaccine Regimen Starts In Sierra Leone (RTTNews)
05.10.15	Johnson & Johnson Announces Completion Of Cordis Divestiture To Cardinal Health (RTTNews)
17.09.15	Achillion Reports Positive Interim Results From Odalasvir Study - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

08:39		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag
27.12.24		Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

08:39

Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen

27.12.24

Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag

27.12.24

Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste

27.12.24

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Johnson & Johnson

Aktien Top/Flop

Johnson & Johnson Peer Group Nachrichten

Meistgelesene Nachrichten